A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy

15340BHV7000-303Open (affiliates only)A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset EpilepsyNCT06132893IndustrialAdultTreatmentOtherTirol, FrancisMedStar Health at McLean VAMedStar Neuroscience & Rehab Research Network7252Petros OkubagziPetros Okubagzipetros.g.okubagzi@medstar.net16327Yemisrach TadesseYemisrach Tadesseyemisrach.g.tadesse@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>